MicroRNA-29a functions as a tumor suppressor through targeting STAT3 in laryngeal squamous cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Laryngeal squamous cell carcinoma (LSCC) presents a significant health challenge with high mortality rates.
• Understanding the molecular drivers of LSCC progression is crucial for developing effective therapeutic strategies.
• MicroRNAs (miRNAs) are key regulators of cellular processes and have emerged as critical players in various cancers.

Purpose of the Study:

• To investigate the potential tumor-suppressive role of microRNA-29a (miR-29a) in laryngeal squamous cell carcinoma.
• To elucidate the molecular mechanisms underlying miR-29a's function in LSCC.
• To identify downstream targets of miR-29a involved in LSCC pathogenesis.

Main Methods:

• Overexpression of miR-29a in LSCC cell lines (AMC-HN-8 and HEP2) in vitro.
• Functional assays to assess cell proliferation, invasion, and migration.
• Western blotting and luciferase reporter assays to identify and validate miR-29a targets.
• Forced expression of STAT3 to assess its interaction with miR-29a's tumor-suppressive function.

Main Results:

• Ectopic expression of miR-29a significantly inhibited proliferation, invasion, and migration of LSCC cells.
• Overexpression of miR-29a led to downregulation of STAT3 expression.
• STAT3 was identified as a direct downstream target of miR-29a in LSCC.
• The tumor-suppressive effects of miR-29a were abrogated by the forced expression of STAT3.

Conclusions:

• MiR-29a functions as a tumor suppressor in laryngeal squamous cell carcinoma.
• MiR-29a exerts its tumor-suppressive effects, at least in part, by directly targeting and downregulating STAT3.
• These findings highlight the potential of targeting the miR-29a/STAT3 axis for novel LSCC therapeutic strategies.